BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 30336198)

  • 1. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
    Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
    Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages.
    Taddei RN; Sanchez-Mico MV; Bonnar O; Connors T; Gaona A; Denbow D; Frosch MP; Gómez-Isla T
    Acta Neuropathol Commun; 2022 May; 10(1):72. PubMed ID: 35534858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
    Luterman JD; Haroutunian V; Yemul S; Ho L; Purohit D; Aisen PS; Mohs R; Pasinetti GM
    Arch Neurol; 2000 Aug; 57(8):1153-60. PubMed ID: 10927795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles.
    Andrade-Moraes CH; Oliveira-Pinto AV; Castro-Fonseca E; da Silva CG; Guimarães DM; Szczupak D; Parente-Bruno DR; Carvalho LR; Polichiso L; Gomes BV; Oliveira LM; Rodriguez RD; Leite RE; Ferretti-Rebustini RE; Jacob-Filho W; Pasqualucci CA; Grinberg LT; Lent R
    Brain; 2013 Dec; 136(Pt 12):3738-52. PubMed ID: 24136825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's-related changes in non-demented essential tremor patients vs. controls: links between tau and tremor?
    Pan JJ; Lee M; Honig LS; Vonsattel JP; Faust PL; Louis ED
    Parkinsonism Relat Disord; 2014 Jun; 20(6):655-8. PubMed ID: 24679899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.
    Zhang M; Ganz AB; Rohde S; Rozemuller AJM; Bank NB; Reinders MJT; Scheltens P; Hulsman M; Hoozemans JJM; Holstege H
    Alzheimers Dement; 2023 Jul; 19(7):2831-2841. PubMed ID: 36583547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
    Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
    Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.
    Hüll M; Strauss S; Berger M; Volk B; Bauer J
    Behav Brain Res; 1996 Jun; 78(1):37-41. PubMed ID: 8793035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies.
    Katsuse O; Iseki E; Kosaka K
    Neuropathology; 2003 Mar; 23(1):9-15. PubMed ID: 12722921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
    Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
    J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model.
    Sankar SB; Infante-Garcia C; Weinstock LD; Ramos-Rodriguez JJ; Hierro-Bujalance C; Fernandez-Ponce C; Wood LB; Garcia-Alloza M
    J Neuroinflammation; 2020 Jan; 17(1):38. PubMed ID: 31992349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Asby D; Boche D; Allan S; Love S; Miners JS
    Brain; 2021 Jul; 144(6):1869-1883. PubMed ID: 33723589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.
    Taddei RN; Perbet R; Mate de Gerando A; Wiedmer AE; Sanchez-Mico M; Connors Stewart T; Gaona A; Melloni A; Amaral AC; Duff K; Frosch MP; Gómez-Isla T
    JAMA Neurol; 2023 Nov; 80(11):1209-1221. PubMed ID: 37812432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.
    Gefen T; Gasho K; Rademaker A; Lalehzari M; Weintraub S; Rogalski E; Wieneke C; Bigio E; Geula C; Mesulam MM
    Brain; 2012 May; 135(Pt 5):1554-65. PubMed ID: 22522938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia.
    Walker DG; Whetzel AM; Lue LF
    Neuroscience; 2015 Aug; 302():121-37. PubMed ID: 25286386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?
    Abner EL; Kryscio RJ; Schmitt FA; Santacruz KS; Jicha GA; Lin Y; Neltner JM; Smith CD; Van Eldik LJ; Nelson PT
    J Alzheimers Dis; 2011; 25(3):445-53. PubMed ID: 21471646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.
    Morimoto K; Horio J; Satoh H; Sue L; Beach T; Arita S; Tooyama I; Konishi Y
    J Alzheimers Dis; 2011; 25(1):59-76. PubMed ID: 21368376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.